Meridian Bioscience TruQuick
Meridian Bioscience has launched TruQuick, a comprehensive point-of-care product menu of rapid tests for the diagnosis of tropical, infectious, sexually transmitted, respiratory, gastrointestinal, cancer, and cardiac diseases. TruQuick is a qualitative lateral flow chromatographic immunoassay menu of over 60 products. Its rapid tests can aid in the diagnosis of infectious pathogens and other important acute diseases in 10 to 20 minutes, the company said.
Biodesix GeneStrat Expansion
Biodesix has broadened its GeneStrat liquid biopsy test to include ROS1 and RET mutations in addition to EGFR sensitizing, EGFR resistance, KRAS, BRAF, and EML4-ALK alterations. GeneStrat is a part of Biodesix's larger "Lung Reflex" multi-omic liquid biopsy testing strategy, which also includes the VeriStrat proteomic testing. Results are available within 72 hours. GeneStrat and VeriStrat together deliver comprehensive information for physicians to support critical treatment decisions at initial diagnosis, expediting appropriate treatment, the company said.
Sygnis has launched TrueHelix, a web-accessible bioinformatics platform for next-generation sequencing analysis services. The first tool released on it will be TruePure, a sample purity validation service that checks for contamination from environmental or other sources. Sygnis said it plans to add more tools over the course of the year.
For more new products and services, please visit the New Products page on our website.